You have 9 free searches left this month | for more free features.

Nonsmall-cell lung cancer(NSCLC)

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Nonsmall Cell Lung Cancer, Nonsmall Cell Lung Cancer, Stage II, Nonsmall Cell Lung Cancer Stage III Trial in Tampa (Genomically

Recruiting
  • Nonsmall Cell Lung Cancer
  • +3 more
  • Genomically Guided Radiation Therapy (RT)
  • Tampa, Florida
    Moffitt Cancer Center
May 23, 2023

Lung Cancer, Nonsmall Cell, Lung Cancer Stage III Trial (combination product, drug, procedure, radiation)

Not yet recruiting
  • Lung Cancer, Nonsmall Cell
  • Lung Cancer Stage III
  • Nivolumab and Chemotherapy
  • +3 more
  • (no location specified)
Aug 15, 2023

Non-Small Cell Lung Carcinoma Trial (Capmatinib 150 mg, Capmatinib 200 mg)

Recruiting
  • Non-Small Cell Lung Carcinoma
  • Capmatinib 150 mg
  • Capmatinib 200 mg
  • Guwahati, Assam, India
  • +7 more
Dec 19, 2022

NSCLC Trial in China (Pembrolizumab, Lenvatinib, Placebo for lenvatinib)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • Pembrolizumab
  • +2 more
  • Hefei, Anhui, China
  • +16 more
Oct 14, 2022

ICIs Combined With Chemotherapy in Advanced NSCLC

Recruiting
  • Lung Cancer, Nonsmall Cell
    • Nanjing, Jiangsu, China
      Shuhua Han
    Feb 10, 2023

    NSCLC, NSCLC, Nonsmall Cell Lung Cancer Trial in Saint Louis (Nintedanib)

    Active, not recruiting
    • Carcinoma, Non-Small-Cell Lung
    • +2 more
    • Saint Louis, Missouri
      Washington University School of Medicine
    Jan 3, 2023

    Lung Cancer, Nonsmall Cell Trial in Sacramento ([18F]F-AraG Imaging)

    Enrolling by invitation
    • Lung Cancer, Nonsmall Cell
    • [18F]F-AraG Imaging
    • Sacramento, California
      UC Davis EXPLORER Molecular Imaging Center
    Jan 4, 2023

    Non Small Cell Lung Cancer, NSCLC Trial in Saint Louis (CoreDx Pulmonary Mini-Forceps)

    Completed
    • Non Small Cell Lung Cancer
    • NSCLC
    • CoreDx Pulmonary Mini-Forceps
    • Saint Louis, Missouri
      Washington University School of Medicine
    Feb 25, 2022

    Lung Cancer, Nonsmall Cell, Lung Cancer Stage IV, Lung Cancer Metastatic Trial in Canada, United States (SLC-391, Pembrolizumab)

    Not yet recruiting
    • Lung Cancer, Nonsmall Cell
    • +2 more
    • Indianapolis, Indiana
    • +8 more
    May 5, 2023

    Nonsmall Cell Lung Cancer Trial in Goyang-Si (Lorlatinib)

    Recruiting
    • Nonsmall Cell Lung Cancer
    • Goyang-Si, Gyeonggi-do, Korea, Republic of
      National Cancer Center
    Apr 4, 2022

    Nonsmall Cell Lung Cancer Trial in New York (Durvalumab, Tremelimumab)

    Not yet recruiting
    • Nonsmall Cell Lung Cancer
    • New York, New York
      Columbia University Irving Medical Center
    Apr 29, 2022

    Observes Afatinib as First-line Treatment and Sequential Therapy

    Active, not recruiting
    • Non-squamous, Non-Small Cell Lung Cancer
    • Beijing, China
    • +9 more
    Jan 9, 2023

    Lung Cancer, Nonsmall Cell Trial in Lebanon (IRX4204, erlotinib)

    Suspended
    • Lung Cancer, Nonsmall Cell
    • Lebanon, New Hampshire
      Geisel School of Medicine at Dartmouth
    Mar 29, 2022

    Assessed With Liquid Biopsy in ICIs Treated NSCLC Patients

    Recruiting
    • Lung Neoplasms
    • +3 more
    • Observation
    • Shanghai, China
      Shanghai Chest Hospital
    Mar 14, 2022

    Lung Cancer, Nonsmall Cell Trial in United Kingdom (Pembrolizumab 25 MG/ML [Keytruda])

    Recruiting
    • Lung Cancer, Nonsmall Cell
    • Pembrolizumab 25 MG/ML [Keytruda]
    • Manchester, United Kingdom
    • +3 more
    Aug 4, 2022

    Nonsmall Cell Lung Cancer Trial in Anaheim, Beverly Hills, Aurora (HS-10296)

    Active, not recruiting
    • Nonsmall Cell Lung Cancer
    • Anaheim, California
    • +9 more
    Dec 27, 2022

    Metastatic Solid Tumor, Colon Cancer, Nonsmall Cell Lung Cancer Trial in France, Switzerland, United Kingdom (1.0% IP-001 for

    Recruiting
    • Metastatic Solid Tumor
    • +3 more
    • 1.0% IP-001 for Injection
    • Bordeaux, France
    • +9 more
    Jan 26, 2023

    Carcinoma, Non-Small Cell Lung, NSCLC, Non-Small-Cell Lung Carcinoma Trial (Capmatinib)

    Available
    • Carcinoma, Non-Small Cell Lung
    • +3 more
    • (no location specified)
    Aug 31, 2021

    NSCLC, NSCLC, Non-Small Cell Lung Carcinoma Trial in United States (efineptakin alfa, Atezolizumab)

    Recruiting
    • Carcinoma, Non-Small-Cell Lung
    • +4 more
    • Mobile, Alabama
    • +14 more
    May 12, 2022

    Lung Cancer, Nonsmall Cell Trial (Pembrolizumab, Carboplatin, Paclitaxel)

    Not yet recruiting
    • Lung Cancer, Nonsmall Cell
    • (no location specified)
    May 7, 2021

    Nonsmall Cell Lung Cancer Stage III, Unresectable Non-Small Cell Lung Carcinoma Trial in Winston-Salem (drug, other, diagnostic

    Not yet recruiting
    • Nonsmall Cell Lung Cancer Stage III
    • Unresectable Non-Small Cell Lung Carcinoma
    • Winston-Salem, North Carolina
      Wake Forest Baptist Comprehensive Cancer Center
    Jan 12, 2023

    Lung Cancer, Nonsmall Cell, Lung Cancer Stage I, Lung Cancer Stage II Trial in Columbia (Breathe Easier Progressive Web

    Not yet recruiting
    • Lung Cancer, Nonsmall Cell
    • +3 more
    • Breathe Easier Progressive Web Application
    • Columbia, South Carolina
      University of South Carolina
    Sep 22, 2023

    Non Small Cell Lung Cancer, NSCLC, Lung Cancer Trial in Port Saint Lucie, Greenville (BL-B01D1)

    Recruiting
    • Non Small Cell Lung Cancer
    • +2 more
    • Port Saint Lucie, Florida
    • +1 more
    Aug 11, 2023

    Lung Cancer, Nonsmall Cell, Quality of Life, Physical Disability Trial in Rio De Janeiro (ADL-Glittre Test)

    Enrolling by invitation
    • Lung Cancer, Nonsmall Cell
    • +3 more
    • ADL-Glittre Test
    • Rio De Janeiro, Brazil
      Centro Universitário Augusto Motta
    May 8, 2023